Monogram Orthopaedics Inc
NASDAQ:MGRM
Cash Flow Statement
Cash Flow Statement
Monogram Orthopaedics Inc
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
(14)
|
(18)
|
(16)
|
(17)
|
(14)
|
(13)
|
(12)
|
(16)
|
(16)
|
(16)
|
(18)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
4
|
5
|
3
|
1
|
(1)
|
(1)
|
(1)
|
2
|
3
|
3
|
5
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
1
|
0
|
2
|
1
|
0
|
1
|
(0)
|
(1)
|
0
|
0
|
|
| Cash from Operating Activities |
(8)
N/A
|
(11)
-34%
|
(12)
-7%
|
(14)
-14%
|
(14)
+2%
|
(14)
-6%
|
(11)
+21%
|
(14)
-25%
|
(14)
+1%
|
(13)
+10%
|
(12)
+4%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-4%
|
(0)
-4%
|
(0)
N/A
|
(0)
+75%
|
(0)
-2%
|
(0)
+45%
|
(0)
-100%
|
(0)
-16%
|
(0)
-172%
|
(0)
-95%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Common Stock |
14
|
14
|
19
|
19
|
17
|
17
|
2
|
16
|
16
|
16
|
18
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
14
N/A
|
14
+1%
|
19
+40%
|
19
-3%
|
17
-10%
|
17
+0%
|
2
-91%
|
16
+953%
|
16
+2%
|
16
0%
|
18
+13%
|
|
| Change in Cash | ||||||||||||
| Net Change in Cash |
5
N/A
|
2
-56%
|
7
+210%
|
5
-33%
|
3
-32%
|
2
-25%
|
(10)
N/A
|
2
N/A
|
2
+23%
|
3
+54%
|
6
+73%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(9)
N/A
|
(12)
-33%
|
(12)
-7%
|
(14)
-13%
|
(14)
+3%
|
(14)
-6%
|
(11)
+22%
|
(14)
-25%
|
(14)
+1%
|
(13)
+8%
|
(13)
+2%
|
|